Deltex Medical Financials
| DEMG Stock | 0.08 0.00 0.00% |
Operating Margin (0.42) | Profit Margin (0.72) | Return On Equity (0.57) |
Deltex | Select Account or Indicator |
Understanding current and past Deltex Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Deltex Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Deltex Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Deltex Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Deltex Medical Group. Check Deltex Medical's Beneish M Score to see the likelihood of Deltex Medical's management manipulating its earnings.
Deltex Medical Stock Summary
Deltex Medical competes with Mulberry Group, Ikigai Ventures, Neometals, Coor Service, and Fidelity Sustainable. Deltex Medical is entity of United Kingdom. It is traded as Stock on LSE exchange.| Foreign Associate | USA |
Specialization | Health Care, Health Care Equipment & Services |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| ISIN | GB0059337583 |
| Business Address | Terminus Road, Chichester, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.deltexmedical.com |
| Phone | 44 12 4377 4837 |
You should never invest in Deltex Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Deltex Stock, because this is throwing your money away. Analyzing the key information contained in Deltex Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Deltex Medical Key Financial Ratios
There are many critical financial ratios that Deltex Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Deltex Medical Group reports annually and quarterly.| Revenue | 1.78 M | ||||
| Gross Profit | 1.84 M | ||||
| EBITDA | (1 M) | ||||
| Net Income | (1.26 M) | ||||
| Total Asset | 5.93 M |
Deltex Medical Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 6.5M | 5.5M | 5.4M | 6.2M | 5.9M | 5.5M | |
| Other Current Liab | 1.7M | 975K | 908K | 784K | 530K | 503.5K | |
| Net Debt | 704K | 614K | 1.6M | 1.8M | 1.2M | 1.3M | |
| Retained Earnings | (53.8M) | (54.6M) | (55.6M) | (56.6M) | (57.8M) | (60.7M) | |
| Accounts Payable | 381K | 201K | 298K | 507K | 173K | 164.4K | |
| Cash | 908K | 853K | 413K | 471K | 705K | 920.5K | |
| Inventory | 915K | 895K | 796K | 821K | 716K | 782.2K | |
| Other Current Assets | 49K | 198K | 175K | 227K | 171K | 162.5K | |
| Total Liab | 3.8M | 2.9M | 3.5M | 3.9M | 2.8M | 3.1M | |
| Total Current Assets | 3.3M | 2.5M | 1.8M | 2.0M | 1.8M | 2.7M | |
| Short Term Debt | 220K | 200K | 748K | 987K | 137K | 130.2K | |
| Common Stock | 5.2M | 5.8M | 5.8M | 7.0M | 7.2M | 7.6M | |
| Other Liab | 62K | 51K | 57K | 64K | 73.6K | 92.9K | |
| Net Receivables | 1.4M | 737K | 455K | 456K | 177K | 168.2K | |
| Long Term Debt | 1.0M | 1.1M | 993K | 1.1M | 1.7M | 996.9K | |
| Intangible Assets | 2.7M | 2.6M | 3.1M | 3.8M | 3.9M | 4.1M | |
| Other Assets | 2.7M | 2.6M | 1.0 | 3.9M | 4.4M | 4.7M | |
| Net Tangible Assets | 2.7M | 2.7M | 2.0M | 2.3M | 2.1M | 2.1M | |
| Short Long Term Debt | 188K | 159K | 702K | 935K | 79K | 75.1K | |
| Net Invested Capital | 4.1M | 3.9M | 3.8M | 4.4M | 5.0M | 4.5M |
Deltex Medical Key Income Statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 176K | 172K | 173K | 199K | 230K | 116.1K | |
| Total Revenue | 4.3M | 2.4M | 2.3M | 2.5M | 1.8M | 1.7M | |
| Gross Profit | 3.1M | 1.5M | 1.5M | 1.7M | 1.1M | 1.1M | |
| Operating Income | 133K | (1.0M) | (1.2M) | (1.0M) | (1.1M) | (1.1M) | |
| Ebit | 133K | (674K) | (862K) | (1.0M) | (1.1M) | (1.2M) | |
| Research Development | 353K | 203K | 167K | 191K | 217K | 268.4K | |
| Ebitda | 366K | (531K) | (748K) | (890K) | (1.0M) | (1.1M) | |
| Cost Of Revenue | 1.1M | 851K | 776K | 735K | 651K | 618.5K | |
| Income Before Tax | (210K) | (846K) | (1.0M) | (1.2M) | (1.4M) | (1.4M) | |
| Net Income | (161K) | (798K) | (967K) | (1.1M) | (1.3M) | (1.3M) | |
| Income Tax Expense | (51K) | (61K) | (69K) | (72K) | (83K) | (78.9K) | |
| Minority Interest | (147K) | (141K) | (139K) | (126K) | (113.4K) | (119.1K) | |
| Tax Provision | (74K) | (51K) | (9K) | (12K) | (1K) | 0.0 | |
| Net Interest Income | (176K) | (172K) | (173K) | (199K) | (230K) | (241.5K) | |
| Interest Income | 135K | 177K | 173K | 171K | 196.7K | 144.5K |
Deltex Medical Key Cash Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (235K) | 13K | 89K | (48K) | 105K | 110.3K | |
| Change In Cash | 328K | (55K) | (440K) | 58K | 234K | 245.7K | |
| Free Cash Flow | 349K | (239K) | (935K) | (1.4M) | (1.6M) | (1.6M) | |
| Depreciation | 233K | 143K | 114K | 128K | 133K | 152.9K | |
| Other Non Cash Items | 189K | 104K | (72K) | 262K | 161K | 169.1K | |
| Capital Expenditures | 260K | 171K | 644K | 744K | 370K | 293.0K | |
| Net Income | (161K) | (798K) | (967K) | (1.1M) | (1.3M) | (1.3M) | |
| End Period Cash Flow | 908K | 853K | 413K | 471K | 705K | 780.0K | |
| Net Borrowings | (389K) | (60K) | 502K | 188K | 216.2K | 227.0K | |
| Change To Netincome | 125K | 195K | 127K | 203K | 182.7K | 149.0K | |
| Investments | (201K) | (171K) | (644K) | (744K) | (370K) | (388.5K) |
Deltex Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Deltex Medical's current stock value. Our valuation model uses many indicators to compare Deltex Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Deltex Medical competition to find correlations between indicators driving Deltex Medical's intrinsic value. More Info.Deltex Medical Group is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Deltex Medical's earnings, one of the primary drivers of an investment's value.Deltex Medical Group Systematic Risk
Deltex Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Deltex Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Deltex Medical Group correlated with the market. If Beta is less than 0 Deltex Medical generally moves in the opposite direction as compared to the market. If Deltex Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Deltex Medical Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Deltex Medical is generally in the same direction as the market. If Beta > 1 Deltex Medical moves generally in the same direction as, but more than the movement of the benchmark.
Deltex Medical Group Total Assets Over Time
Deltex Medical Thematic Clasifications
Deltex Medical Group is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Deltex Medical December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Deltex Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Deltex Medical Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Deltex Medical Group based on widely used predictive technical indicators. In general, we focus on analyzing Deltex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Deltex Medical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.29) | |||
| Maximum Drawdown | 13.64 | |||
| Value At Risk | (7.69) |
Additional Tools for Deltex Stock Analysis
When running Deltex Medical's price analysis, check to measure Deltex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Deltex Medical is operating at the current time. Most of Deltex Medical's value examination focuses on studying past and present price action to predict the probability of Deltex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Deltex Medical's price. Additionally, you may evaluate how the addition of Deltex Medical to your portfolios can decrease your overall portfolio volatility.